These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Frequency and distribution of numerical chromosomal aberrations in prostatic cancer. Henke RP; Krüger E; Ayhan N; Hübner D; Hammerer P Hum Pathol; 1994 May; 25(5):476-84. PubMed ID: 8200641 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non-persistent and metastatic tumours. Alers JC; Krijtenburg PJ; Hop WC; Bolle WA; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H J Pathol; 1998 Jul; 185(3):273-83. PubMed ID: 9771481 [TBL] [Abstract][Full Text] [Related]
5. Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNA. Hepburn PJ; Glynne-Jones E; Goddard L; Gee JM; Harper ME Histochem J; 1995 Mar; 27(3):196-203. PubMed ID: 7797424 [TBL] [Abstract][Full Text] [Related]
6. Expression of proliferation associated antigens and detection of numerical chromosome aberrations in primary human liver tumours: relevance to tumour characteristics and prognosis. Nolte M; Werner M; Nasarek A; Bektas H; von Wasielewski R; Klempnauer J; Georgii A J Clin Pathol; 1998 Jan; 51(1):47-51. PubMed ID: 9577372 [TBL] [Abstract][Full Text] [Related]
7. Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy. Bubendorf L; Sauter G; Moch H; Schmid HP; Gasser TC; Jordan P; Mihatsch MJ J Pathol; 1996 Apr; 178(4):437-41. PubMed ID: 8691323 [TBL] [Abstract][Full Text] [Related]
8. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy. Bettencourt MC; Bauer JJ; Sesterhenn IA; Mostofi FK; McLeod DG; Moul JW J Urol; 1996 Sep; 156(3):1064-8. PubMed ID: 8709308 [TBL] [Abstract][Full Text] [Related]
9. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen. Yu CC; Dublin EA; Camplejohn RS; Levison DA Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754 [TBL] [Abstract][Full Text] [Related]
10. Numerical chromosomal aberrations in transition-zone carcinomas of the prostate. Erbersdobler A; Hammerer P; Huland H; Henke RP J Urol; 1997 Oct; 158(4):1594-8. PubMed ID: 9302180 [TBL] [Abstract][Full Text] [Related]
11. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract. Lee CS Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306 [TBL] [Abstract][Full Text] [Related]
12. DNA in situ hybridization (interphase cytogenetics) versus comparative genomic hybridization (CGH) in human cancer: detection of numerical and structural chromosome aberrations. Van Dekken H; Krijtenburg PJ; Alers JC Acta Histochem; 2000 Feb; 102(1):85-94. PubMed ID: 10726167 [TBL] [Abstract][Full Text] [Related]
13. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone. Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787 [TBL] [Abstract][Full Text] [Related]
14. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607 [TBL] [Abstract][Full Text] [Related]
15. Correlation of non-random chromosomal aberrations in lymphocytes of prostate cancer patients with specific clinical parameters. Ozen M; Hopwood VL; Balbay MD; Johnston DA; Babaian RJ; Logothetis CJ; von Eschenbach AC; Pathak S Int J Oncol; 2000 Jul; 17(1):113-7. PubMed ID: 10853027 [TBL] [Abstract][Full Text] [Related]
16. Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry. Krishnadath KK; Tilanus HW; Alers JC; Mulder AH; van Dekken H Cytometry; 1994 Feb; 15(2):176-84. PubMed ID: 8168405 [TBL] [Abstract][Full Text] [Related]
17. Detection of trisomy 7 with fluorescence in situ hybridization and its correlation with DNA content and proliferating cell nuclear antigen-positivity in prostate cancer. Matturri L; Biondo B; Cazzullo A; Montanari E; Radice F; Timossi R; Turconi P; Lavezzi AM Am J Clin Oncol; 1998 Jun; 21(3):253-7. PubMed ID: 9626793 [TBL] [Abstract][Full Text] [Related]
18. Numerical chromosomal changes in high-grade prostatic intraepithelial neoplasia (PIN) and concomitant invasive carcinoma. Erbersdobler A; Gürses N; Henke RP Pathol Res Pract; 1996 May; 192(5):418-27. PubMed ID: 8832746 [TBL] [Abstract][Full Text] [Related]
19. A comparative study on aberrations of chromosome 17 and proliferating cell fraction in lung cancer. Lee KJ; Lee MS; Kim JO; Kim SY J Korean Med Sci; 1993 Aug; 8(4):271-80. PubMed ID: 7911024 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. Cattoretti G; Becker MH; Key G; Duchrow M; Schlüter C; Galle J; Gerdes J J Pathol; 1992 Dec; 168(4):357-63. PubMed ID: 1484317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]